Lidocaine Hydrochloride Patent Expiration
Lidocaine Hydrochloride is Used for providing local anesthesia with the delivery of powdered lidocaine hydrochloride monohydrate. It was first introduced by Fresenius Kabi Usa Llc
Lidocaine Hydrochloride Patents
Given below is the list of patents protecting Lidocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Zingo | US9370622 | Devices and methods for delivering particles | Sep 28, 2035 | Powder Pharms |
Zingo | US9358338 | Particle cassettes and processes therefor | Apr 27, 2035 | Powder Pharms |
Zingo | US8540665 | Particle cassettes and processes therefor | Oct 22, 2029 | Powder Pharms |
Akten | US8759401 | Aqueous gel formulation and method for inducing topical anesthesia | Jul 24, 2026 | Thea Pharma |
Zingo | US6004286 | Particle delivery |
Mar 17, 2017
(Expired) | Powder Pharms |
Zingo | US6881200 | Needleless syringe using super sonic gas flow for particle delivery |
Jun 11, 2016
(Expired) | Powder Pharms |
Zingo | US5899880 | Needleless syringe using supersonic gas flow for particle delivery |
May 04, 2016
(Expired) | Powder Pharms |
Zingo | US5630796 | Method of delivering powder transdermally with needless injector |
May 20, 2014
(Expired) | Powder Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Lidocaine Hydrochloride's patents.
Latest Legal Activities on Lidocaine Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Lidocaine Hydrochloride.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Maintenance Fee Reminder Mailed Critical
| 12 Feb, 2024 | US9370622 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Mar, 2021 | US8540665 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 03 Jul, 2019 | US9370622 |
Recordation of Patent Grant Mailed Critical
| 21 Jun, 2016 | US9370622 |
Patent Issue Date Used in PTA Calculation Critical
| 21 Jun, 2016 | US9370622 |
Issue Notification Mailed Critical
| 01 Jun, 2016 | US9370622 |
Dispatch to FDC | 24 May, 2016 | US9370622 |
Application Is Considered Ready for Issue Critical
| 20 May, 2016 | US9370622 |
Issue Fee Payment Verified Critical
| 20 May, 2016 | US9370622 |
Issue Fee Payment Received Critical
| 20 May, 2016 | US9370622 |
Lidocaine Hydrochloride's Family Patents
